These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3337061)

  • 21. Proceedings of the First International Symposium on Olsalazine in the Treatment of Ulcerative Colitis. Oxford, March 1987.
    Scand J Gastroenterol Suppl; 1988; 148():1-109. PubMed ID: 3227306
    [No Abstract]   [Full Text] [Related]  

  • 22. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
    Baker DE; Kane S
    Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical management of ulcerative colitis.
    Goggins M
    Ir Med J; 1993; 86(4):112-3. PubMed ID: 8360037
    [No Abstract]   [Full Text] [Related]  

  • 24. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.
    Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ
    Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Salozosulphapyridine and its metabolites in ulcerative colitis and Crohn disease].
    Rubinstein BE
    Ugeskr Laeger; 1982 Feb; 144(5):304-6. PubMed ID: 6122297
    [No Abstract]   [Full Text] [Related]  

  • 26. 5-Aminosalicylic acid for the treatment of inflammatory bowel disease.
    Dew MJ; Evans BK; Rhodes J
    Gastroenterology; 1984 Aug; 87(2):480-1. PubMed ID: 6735091
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral 4-aminosalicylic acid therapy in ulcerative colitis.
    Gaffney P; Doyle C; Gaffney A
    Gastroenterology; 1992 Nov; 103(5):1706-7. PubMed ID: 1426895
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study.
    d'Albasio G; Pacini F; Camarri E; Messori A; Trallori G; Bonanomi AG; Bardazzi G; Milla M; Ferrero S; Biagini M; Quaranta S; Amorosi A
    Am J Gastroenterol; 1997 Jul; 92(7):1143-7. PubMed ID: 9219787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current orientation in medical management of ulcerative colitis].
    Grassi M; Raffa S; Damiani VC; Fontana M
    Clin Ter; 1995 May; 146(5):327-41. PubMed ID: 7796565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The treatment of ulcerative colitis].
    Turunen U; Järvinen HJ
    Duodecim; 1993; 109(2):145-51. PubMed ID: 7912179
    [No Abstract]   [Full Text] [Related]  

  • 31. [Autoimmune hemolytic anemia and ulcerative colitis].
    Rebocho L; Lucas M; Victorino RM
    Acta Med Port; 1995 Dec; 8(12):701-3. PubMed ID: 8669321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on medical management of inflammatory bowel disease: ulcerative colitis.
    Hanauer SB
    Rev Gastroenterol Disord; 2001; 1(4):169-76. PubMed ID: 12120183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colonic targeting of aminosalicylates for the treatment of ulcerative colitis.
    Klotz U
    Dig Liver Dis; 2005 Jun; 37(6):381-8. PubMed ID: 15893274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ulcerative colitis. Evaluation of a newly developed activity index within the scope of a therapeutic study of mesalazin].
    Maier K; von Gaisberg U; Kraus B; Kimmig JM; Tippmann P; Gerhard F; Lepiorz P
    Fortschr Med; 1987 Jan; 105(2):61, 65-6, 69. PubMed ID: 3557255
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ulcerative colitis. Maintenance therapy].
    Kruis W; Schreiber S
    Z Gastroenterol; 2004 Sep; 42(9):1011-4. PubMed ID: 15455275
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of ulcerative colitis with 5-aminosalicylic acid.
    Sninsky CA
    Ann Intern Med; 1993 Oct; 119(8):858-9. PubMed ID: 8379609
    [No Abstract]   [Full Text] [Related]  

  • 37. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology and ulcerative colitis.
    Ponichtera PB; Fitzgerald MA
    Clin Excell Nurse Pract; 1998 Mar; 2(2):67-72. PubMed ID: 10451266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity].
    Loizeau E
    Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252
    [No Abstract]   [Full Text] [Related]  

  • 40. 5-Aminosalicylic acid in pregnancy: clinical report.
    Trallori G; d'Albasio G; Bardazzi G; Bonanomi AG; Amorosi A; Del Carlo P; Palli D; Galli M; Pacini F
    Ital J Gastroenterol; 1994 Mar; 26(2):75-8. PubMed ID: 8032081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.